Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects

A new fixed-dose combination formulation of evogliptin 5 mg and metformin extended-release (XR) 1,000 mg (FDC_EVO5/MET1000) was developed to improve medication adherence for type 2 diabetes mellitus. The pharmacokinetics of FDC_EVO5/MET1000 was compared to the corresponding loose combination in a ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Rhee, Su-jin, Lee, SeungHwan, Yoon, Seo Hyun, Cho, Joo-Youn, Jang, In-Jin, Yu, Kyung-Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835124/
https://www.ncbi.nlm.nih.gov/pubmed/27110098
http://dx.doi.org/10.2147/DDDT.S102459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835124/
https://www.ncbi.nlm.nih.gov/pubmed/27110098
http://dx.doi.org/10.2147/DDDT.S102459

Ejemplares similares